Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 1MG | TABLET | Resolved | 2024-07-12 | 2024-09-20 | 232846 |
| APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 225014 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-08-08 | 375 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Resolved | 2021-06-18 | 2021-09-20 | 141244 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Resolved | 2018-03-20 | 2018-06-12 | 43511 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Resolved | 2017-10-23 | 2018-01-22 | 26594 |
| APO-LORAZEPAM TAB 2MG | 2MG | TABLET | Resolved | 2022-04-01 | 2022-05-13 | 157698 |
| APO-LORAZEPAM TAB 2MG | 2MG | TABLET | Resolved | 2021-08-03 | 2021-09-07 | 143401 |
| APO-LORAZEPAM TAB 2MG | 2MG | TABLET | Resolved | 2020-08-12 | 2020-10-05 | 122071 |
| APO-LORAZEPAM TAB 2MG | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
| APO-LOSARTAN | 25MG | TABLET | Actual shortage | 2018-07-11 | 2019-03-15 | 55284 |
| APO-LOSARTAN | 50MG | TABLET | Resolved | 2017-03-12 | 2017-03-16 | 722 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-05-15 | 2019-04-11 | 49490 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-12-27 | 2019-04-17 | 70523 |
| APO-LOSARTAN | 50MG | TABLET | Actual shortage | 2018-05-01 | 2019-03-15 | 47652 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-02-13 | 2018-09-10 | 39656 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-03-27 | 2018-09-11 | 44105 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-10-24 | 2018-09-11 | 26827 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-05-15 | 2018-09-15 | 49493 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-07-15 | 2018-09-15 | 55807 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
| APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
| APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |
| BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
| COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| DOXEPIN | 100MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65447 |
| DOXEPIN | 10MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65452 |
| DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| DOXEPIN | 75MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65466 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |